DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Vilaprisan is an investigational drug.
There have been 15 clinical trials for Vilaprisan. The most recent clinical trial was a Phase 2 trial, which was initiated on July 31st 2017.
The most common disease conditions in clinical trials are Leiomyoma, Myofibroma, and Endometriosis. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are seven US patents protecting this investigational drug and one hundred and seven international patents.
Recent Clinical Trials for Vilaprisan
|Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids||Bayer||Phase 3|
|Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis||Bayer||Phase 2|
|A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding||Bayer||Phase 3|
Top disease conditions for Vilaprisan
Top clinical trial sponsors for Vilaprisan
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Vilaprisan||Get Started Free||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Get Started Free|
|Vilaprisan||Get Started Free||17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases||BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE)||Get Started Free|
|Vilaprisan||Get Started Free||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||Get Started Free|
|Vilaprisan||Get Started Free||Compartmented pharmaceutical dosage forms||Triastek, Inc. (Nanjing, CN)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Vilaprisan||Australia||AU2017261372||2036-05-05||Get Started Free|
|Vilaprisan||Canada||CA3023278||2036-05-05||Get Started Free|
|Vilaprisan||China||CN107847398||2036-05-05||Get Started Free|
|Vilaprisan||European Patent Office||EP3452003||2036-05-05||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|